Evidence map›Paper›PMID 40517169›Full record

ArticleOncogene2025

Targeting TFAM downregulation mediated mtDNA-NLRP3 pathway suppresses TAM infiltration and HCC progression.

Jing Zhao, Mengmeng Cui, Xiaojuan Yao, Zhixiong Jiang, Lixia Qi, Jiaxing Chen, Chunhui Fan, Shuwen Bai, Chengying Zhou, Rui Wei and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jing Zhao *Laboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Henan University, Kaifeng, 475000, Henan, China.
Mengmeng Cui *Laboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Henan University, Kaifeng, 475000, Henan, China.
Xiaojuan Yao *Laboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Henan University, Kaifeng, 475000, Henan, China.
Zhixiong JiangLaboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Henan University, Kaifeng, 475000, Henan, China.
Lixia QiLaboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Henan University, Kaifeng, 475000, Henan, China.
Jiaxing ChenLaboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Henan University, Kaifeng, 475000, Henan, China.
Chunhui FanLaboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Henan University, Kaifeng, 475000, Henan, China.
Shuwen BaiFirst Affiliated Hospital of Henan University, Kaifeng, Henan, 475000, China.
Chengying ZhouHuaihe Hospital of Henan University, Kaifeng, Henan, 475000, China.
Rui WeiHuaihe Hospital of Henan University, Kaifeng, Henan, 475000, China.
Hongliang LiuLaboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Henan University, Kaifeng, 475000, Henan, China.
Qi YangLaboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Henan University, Kaifeng, 475000, Henan, China. yangqi_456@126.com.
Lixin WanHenan Engineering Research Center for Molecular Diagnosis and Therapy of Esophageal Cancer, Nanyang central Hospital, Henan University, Nanyang, Henan, 473000, China. nanyang1967@163.com.
Dengke BaoLaboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Henan University, Kaifeng, 475000, Henan, China. bdkmydy12004@126.com.ORCID http://orcid.org/0000-0002-6503-934X

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82002511National Natural Science Foundation of China (National Science Foundation of China) 82373070
6 · The paper itself

Abstract

The infiltration of TAMs mediates an immunosuppressive tumor microenvironment, which plays a crucial role in the malignant progression of HCC. TFAM is a key molecule that regulates mtDNA replication and transcription, and its expression frequently downregulated in various tumors, including HCC. Our previous study indicated that the downregulation of TFAM triggers mtDNA stress, thereby inducing autophagy and promoting ESCC survival through the STING pathway. However, it remains unclear whether cytosolic mtDNA stress, mediated by TFAM downregulation, is implicated in microenvironment regulation, particularly in the infiltration of TAMs in HCC. In this study, we found that TFAM expression was significantly decreased and correlated with CD163 expression in HCC tissues. The downregulated expression of TFAM in HCC cells contributed to TAM infiltration. Mechanistically, the downregulation of TFAM induced cytosolic mtDNA stress, which activated the NLRP3 inflammasome and promoted the expression of IL-18 and IL-1β in HCC cells, thereby inducing macrophage recruitment and M2 polarization. Depleting cytosolic mtDNA using DNase I or blocking NLRP3 inflammasome activation with an NLRP3 antagonist in HCC cells with TFAM downregulation significantly suppresses the infiltration of M2-TAMs. Moreover, blocking the mtDNA-NLRP3 pathway significantly inhibited TAM infiltration and orthotopic mouse HCC model progression. Taken together, our results reveal a novel mechanism by which cytosolic mtDNA stress mediates TAM infiltration in HCC.

Indexed as

Carcinoma, HepatocellularDNA-Binding ProteinsDNA, MitochondrialHigh Mobility Group ProteinsLiver NeoplasmsMitochondrial ProteinsNLR Family, Pyrin Domain-Containing 3 ProteinTranscription FactorsAnimalsCell Line, TumorDisease ProgressionDown-RegulationFemaleGene Expression Regulation, NeoplasticHumansInflammasomesDNA-Binding ProteinsDNA, MitochondrialHigh Mobility Group ProteinsInflammasomesMitochondrial ProteinsNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanTFAM protein, humanTranscription Factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.